Gyre Therapeutics Inc. (GYRE) financials · rev $116.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Gyre Therapeutics Inc. (GYRE) rev $116.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $116.6M | $105.8M |
| Cost of Revenue | $5.42M | $3.88M |
| Gross Profit | $111.2M | $101.9M |
| Operating Income | $11.5M | $16.2M |
| Net Income | $9.88M | $17.9M |
| EPS (Diluted) | $0.02 | $0.05 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $166.1M | $125.4M |
| Current Assets | $102.4M | $64.8M |
| Cash & Equivalents | $37.1M | $11.8M |
| Inventory | $10.2M | $6.34M |
| PP&E | $23.6M | $23.9M |
| Total Liabilities | $23.9M | $27.0M |
| Current Liabilities | $18.3M | $19.5M |
| Shareholders' Equity | $106.0M | $63.3M |
| Retained Earnings | -$68.4M | -$73.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $1.01M | -$3.64M |
| CapEx | $1.19M | $2.31M |
| Investing Cash Flow | -$474.0K | -$19.9M |
| Financing Cash Flow | $24.4M | $2.10M |
| Net Change in Cash | $25.3M | -$21.7M |
| Free Cash Flow | -$180.0K | -$5.96M |
FAQ
What is GYRE P/E and revenue?
Gyre Therapeutics Inc. (GYRE) rev $116.6M.
What is GYRE revenue?
Gyre Therapeutics Inc. last cached revenue is $116.6M (FY2025).
Is GYRE profitable?
Gyre Therapeutics Inc. last cached net income is $9.88M (FY2025).
What are GYRE total assets?
Gyre Therapeutics Inc. last cached total assets are $166.1M (FY2025).
What is GYRE free cash flow?
Gyre Therapeutics Inc. last cached free cash flow is -$180.0K (FY2025).
Not investment advice. Cached statements, not a live tape.